Anti-Diabetic Tablet Franchise in Ahmedabad

Metformin Voglibose Tablet Supplier in Mumbai

Blood Sugar Control Tablet Distributor in Delhi

Type 2 Diabetes Tablet Manufacturer in Bangalore

Anti-Diabetic Combination Tablet Stockist in Hyderabad
Metformin Voglibose Tablet Exporter in Chandigarh

Home/Products /metformin-1000mg-voglibose-0-3mg-tablet

Vogliviga M 0.3 Forte Tablet

Composition : Metformin (1000mg) + Voglibose (0.3mg) Tablet

Dosage Form : Tablet

Packaging Type : Blister

Packaging : 10*10

Price : ₹1/-

Please Contact For Best Price

Metformin 1000mg + Voglibose 0.3mg tablet is a dual-action anti-diabetic formulation used for the effective management of type 2 diabetes mellitus and postprandial hyperglycemia.

Metformin works by reducing hepatic glucose production and improving insulin sensitivity, while Voglibose slows carbohydrate absorption from the gut, effectively controlling blood sugar spikes after meals.

This tablet is commonly prescribed for patients with type 2 diabetes who require improved glycemic control, especially postprandial glucose management, ensuring stable blood sugar levels and reduced complications.

With proven efficacy, convenient oral dosing, and strong acceptance among physicians and patients, this formulation strengthens an anti-diabetic product portfolio and supports consistent demand in diabetes management.

Read More

About the Product

Metformin 1000mg + Voglibose 0.3mg tablet is a dual-action anti-diabetic formulation used for the effective management of type 2 diabetes mellitus and postprandial hyperglycemia.

Metformin works by reducing hepatic glucose production and improving insulin sensitivity, while Voglibose slows carbohydrate absorption from the gut, effectively controlling blood sugar spikes after meals.

This tablet is commonly prescribed for patients with type 2 diabetes who require improved glycemic control, especially postprandial glucose management, ensuring stable blood sugar levels and reduced complications.

With proven efficacy, convenient oral dosing, and strong acceptance among physicians and patients, this formulation strengthens an anti-diabetic product portfolio and supports consistent demand in diabetes management.

Common side effects may include mild gastrointestinal discomfort, nausea, bloating, diarrhea, or flatulence. Rarely, lactic acidosis or hypoglycemia may occur, especially in patients with renal or hepatic impairment.

Vogliviga M 0.3 Forte Tablet is indicated for the management of type 2 diabetes mellitus, either as monotherapy or in combination with diet, exercise, and other antidiabetic medications, as prescribed by a healthcare professional.

For oral use only. Use strictly under medical supervision. Take with meals to minimize gastrointestinal side effects. Regular monitoring of blood glucose and renal function is recommended during prolonged therapy.

Store below 25°C in a cool, dry place. Protect from moisture and light. Keep out of reach of children.

Get in Touch